Nursing management of targeted therapies for ErbB2 positive breast cancer: developing a quality service

Bucks Knowledge Archive

Show simple item record

dc.contributor.author Depledge, J
dc.date.accessioned 2012-07-18T11:22:39Z
dc.date.available 2012-07-18T11:22:39Z
dc.date.issued 2012-07-18
dc.identifier.uri http://hdl.handle.net/123456789/766
dc.description.abstract EGFR Inhibitors in Metastatic Breast Cancer, Glaxo Smith Kline, Stockley Park West, Uxbridge. 15-17 October 2008, Advisory panel member and delivery of a module presentation en_US
dc.subject Nursing en_US
dc.subject breast cancer en_US
dc.subject cancer en_US
dc.subject service en_US
dc.subject therapies en_US
dc.title Nursing management of targeted therapies for ErbB2 positive breast cancer: developing a quality service en_US
dc.type Other en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account